<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08906092200118</udiDi>
    <basicUdiDi>890609220HPMCJ2</basicUdiDi>
    <tradeName>08906092200118</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EYEVISC PFS 2.4%</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:44:06.884Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200675</udiDi>
    <basicUdiDi>890609220HPMCJ2</basicUdiDi>
    <tradeName>08906092200675</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>METILON 20 PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:44:06.141Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200187</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200187</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:52.405Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200170</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200170</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR PLUS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:35.105Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200071</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200071</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR HV</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:34.010Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200057</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200057</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR EV</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:19.319Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200255</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200255</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR SV</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:17.110Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200408</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200408</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR DUO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:03.906Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200415</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200415</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR DUO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:42:50.199Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200422</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200422</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR DUO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:41:10.320Z</lastUpdated>
  </row>
  <row>
    <udiDi>08588009046035</udiDi>
    <basicUdiDi>8588009045UNItearsPFQ8</basicUdiDi>
    <tradeName>UNItears® be konservantų akių lašai (tirpalas)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Unimed Pharma spol. s r.o.</manufacturerName>
    <manufacturerSrn>SK-MF-000003111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>58</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:40:59.038Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200798</udiDi>
    <basicUdiDi>890609220HPMCJ2</basicUdiDi>
    <tradeName>08906092200798</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>OPTICEL PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:40:05.282Z</lastUpdated>
  </row>
  <row>
    <udiDi>08588009045229</udiDi>
    <basicUdiDi>8588009045HYPROMELOZAPR3</basicUdiDi>
    <tradeName>HYPROMELOZA-P® akių lašai (tirpalas)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Unimed Pharma spol. s r.o.</manufacturerName>
    <manufacturerSrn>SK-MF-000003111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:39:42.857Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974084090209</udiDi>
    <basicUdiDi>697408409Q02030299EYEHP</basicUdiDi>
    <tradeName>Eye Wash</tradeName>
    <deviceName>Eye Wash</deviceName>
    <manufacturerName>Longbow First Aid Products Co.,Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000032024</manufacturerSrn>
    <authorisedRepresentativeName>Shanghai International Holding Corp. GmbH(Europe)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000001</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LBEW</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-02T12:26:14.718Z</lastUpdated>
  </row>
  <row>
    <udiDi>06936020103046</udiDi>
    <basicUdiDi>69360201088U</basicUdiDi>
    <tradeName>Singclean®</tradeName>
    <deviceName>Viscoelastic Solution for Ophthalmic Surgery</deviceName>
    <manufacturerName>Hangzhou Singclean Medical Products Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000014098</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>OPH-SC-15-0.5</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-02T07:04:39.398Z</lastUpdated>
  </row>
  <row>
    <udiDi>05200702400022</udiDi>
    <basicUdiDi>52007024BSSP5</basicUdiDi>
    <tradeName>Balanced Salt Solution (BSS) Bausch+Lomb</tradeName>
    <deviceName>Balanced Salt Solution (BSS)</deviceName>
    <manufacturerName>ΒΙΟΣΕΡ Α.Ε. ΒΙΟΜΗΧΑΝΙΑ ΠΑΡΕΝΤΕΡΙΚΩΝ ΔΙΑΛΥΜΑΤΩΝ</manufacturerName>
    <manufacturerSrn>GR-MF-000013176</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030203</emdnCode>
    <emdnDescription>OPHTHALMIC SURGERY BALANCED SALINE SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSS-10PK</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-01T23:50:01.743Z</lastUpdated>
  </row>
  <row>
    <udiDi>04950055206185</udiDi>
    <basicUdiDi>49500551110P3</basicUdiDi>
    <tradeName>cleadew SLi</tradeName>
    <deviceName>cleadew SLi</deviceName>
    <manufacturerName>OPHTECS Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000014564</manufacturerSrn>
    <authorisedRepresentativeName>OPHTECS Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000011893</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030204</emdnCode>
    <emdnDescription>CONTACT LENSES STORING AND CLEANING SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>75220</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-01T21:58:55.182Z</lastUpdated>
  </row>
  <row>
    <udiDi>471987285</udiDi>
    <basicUdiDi>471987285SC28</basicUdiDi>
    <tradeName>LEXXOO</tradeName>
    <deviceName>Contact Lens Cases</deviceName>
    <manufacturerName>Bonasse Enterprises co., Ltd.</manufacturerName>
    <manufacturerSrn>TW-MF-000001352</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030204</emdnCode>
    <emdnDescription>CONTACT LENSES STORING AND CLEANING SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SC series</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T21:20:43.163Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260741121013</udiDi>
    <basicUdiDi>426074112NVG00129</basicUdiDi>
    <tradeName>NovaTears</tradeName>
    <deviceName>Non-active ophthalmologic devices based on perfluorohexyloctane</deviceName>
    <manufacturerName>Novaliq GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000009618</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0500100001</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T20:08:43.677Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595532970</udiDi>
    <basicUdiDi>426059553MP03UD01JE</basicUdiDi>
    <tradeName>BLUpan® medical UD</tradeName>
    <deviceName>Sodium Hyaluronate - Dexpanthenol Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>41127200</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:34.840Z</lastUpdated>
  </row>
</eudamedExport>